Media
Follow our progress and stay up to date with our press releases and media coverage.
Press Releases
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
In the News
New UNC spin-out targets hemophilia cure through gene therapy
By Seth Thomas Gulledge – Staff Writer, Triangle Business Journal - November 4, 2020 Companies in this article: University of North Carolina at Chapel Hill https://www.unc.edu/, GeneVentiv Therapeutics https:/www.geneventiv.com A new company launching around...
Raleigh’s GeneVentiv Therapeutics signs deal with UNC for potential hemophilia therapy
by Meredith Dockery, North Carolina Business News Wire — November 4, 2020 . RALEIGH — GeneVentiv Therapeutics, Inc., a gene therapy developer, announced a license agreement with the University of North Carolina at Chapel Hill for a patent-pending, gene therapy for...
UNC Spinout GeneVentiv’s Gene Therapy offers a Universal Cure for Hemophilia
November 2, 2020 RALEIGH, NC – GeneVentiv Therapeutics has entered a license agreement with University of North Carolina Chapel Hill for a gene therapy that is a universal cure for Hemophilia A or B patients with or without inhibitors to their missing clotting...